Cargando…
Abrocitinib Attenuates Microglia-Mediated Neuroinflammation after Traumatic Brain Injury via Inhibiting the JAK1/STAT1/NF-κB Pathway
Background and Purpose: Neuroinflammation has been shown to play a critical role in secondary craniocerebral injury, leading to poor outcomes for TBI patients. Abrocitinib, a Janus kinase1 (JAK1) selective inhibitor approved to treat atopic dermatitis (AD) by the Food and Drug Administration (FDA),...
Autores principales: | Li, Tuo, Li, Lei, Peng, Ruilong, Hao, Hongying, Zhang, Hejun, Gao, Yalong, Wang, Cong, Li, Fanjian, Liu, Xilei, Chen, Fanglian, Zhang, Shu, Zhang, Jianning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688110/ https://www.ncbi.nlm.nih.gov/pubmed/36429017 http://dx.doi.org/10.3390/cells11223588 |
Ejemplares similares
-
Recombinant Human Annexin A5 Alleviated Traumatic-Brain-Injury Induced Intestinal Injury by Regulating the Nrf2/HO-1/HMGB1 Pathway
por: Zhang, Hejun, et al.
Publicado: (2022) -
NS1619 Alleviate Brain-Derived Extracellular Vesicle-Induced Brain Injury by Regulating BKca Channel and Nrf2/HO-1/NF-ĸB Pathway
por: Gao, Yalong, et al.
Publicado: (2022) -
Neuroinflammation of traumatic brain injury: Roles of extracellular vesicles
por: Liu, Xilei, et al.
Publicado: (2023) -
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023) -
JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series
por: Xu, Bingyang, et al.
Publicado: (2023)